June 18, 2012 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its participation in the Drug Information Association's (DIA) 2012 Annual Meeting – Collaborate to Innovate. DATATRAK will be exhibiting and giving key presentations during the 48th Annual Meeting held in
Philadelphia, PA on
June 24-28th 2012.
DATATRAK will be exhibiting in Booth #2607 on
June 25th – 27th. Individuals attending the meeting are invited to the booth to view demonstrations of the latest DATATRAK ONE™ unified cloud-based research platform. DATATRAK will use this opportunity to introduce new corporate branding and give a preview of the newly re-designed user interface of its product suite.
As recognized industry experts, the following DATATRAK executives have been invited to present their perspectives and experience during the following sessions:
The Role of Quality Assurance in eClinical Environments – When to Dive in
Innovative Learning Opportunities: A Collaboration between Industry and Academics
- Shiela McLaughlin , Director of Quality Assurance
- Wednesday, June 27th from 1:30PM – 3:00PM
- Track 11: Compliance to Good Clinical Practice (GCP), Good Laboratory Practice (GLP), and Quality Assurance (QA)
- Dr. Bill Gluck , VP DATATRAK's Clinical and Consulting Services
- Thursday, June 28th from 9:00AM - 10:30AM
- Track 16: Professional Development
About DIA Annual MeetingThe 48th Annual DIA Meeting provides an invaluable forum for professionals involved in the discovery, development, and life-cycle management of pharmaceuticals, medical devices, and related products, including discussion of current issues related to new areas such as comparative effectiveness, health outcomes, and medical devices. For more information, visit
About DATATRAK DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I - Phase IV drug and devices studies in multiple languages throughout the world. DATATRAK has offices located in
; and Cary (RTP),
. For more information, visit
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on
May 10, 2012
announcing its results for the three-month period ending
March 31, 2012
. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.